Ilia Toshkov

Medicine · Health Sciences

18h-index1.2kcitations34works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(10), Animal Virus Infections Studies(8), Hepatitis C virus research(7), Hepatocellular Carcinoma Treatment and Prognosis(4), Genetics, Aging, and Longevity in Model Organisms(4)

Publications34 total

Dormant senescence-prone cells (DSPC): a lifetime memory about systemic genotoxic stress
Research Square (Research Square)·2022Open Access
A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications
Communications Biology·2021· 30 citedOpen Access
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer
Oncotarget·2020· 12 citedOpen Access
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis
Leukemia·2020· 61 citedOpen Access
Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation
Radiation Research·2017· 42 citedOpen Access
Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in mice
Aging·2017· 72 citedOpen Access
The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
PLoS ONE·2015· 60 citedOpen Access
Abstract 5144: Low dose sorafenib delays hepatocellular cancer (HCC) development in the woodchuck model of hepatitis B related HCC
Cancer Research·2015Open Access
Abstract 4946: Developing anti-angiogenic therapies for human hepatocellular cancer (HCC)- studies of suntinib in the woodchuck model of hepatitis B related HCC
Cancer Research·2014· 1 cited
Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice
Chronobiology International·2014· 14 cited
Mo1927 Histological Changes Following Sunitinib Therapy in the Woodchuck Model of Hepatitis B Related HCC
Gastroenterology·2014Open Access
Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice
Oncotarget·2014· 38 citedOpen Access
Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis
Cell Cycle·2013· 42 citedOpen Access
Expression of matrix metalloproteinases and their inhibitors in the woodchuck model of hepatocellular carcinoma
Journal of Medical Virology·2013· 12 citedOpen Access
New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
Aging·2012· 116 citedOpen Access
Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks
Hepatology·2012· 32 citedOpen Access
Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
International Journal of Radiation Oncology*Biology*Physics·2011· 116 citedOpen Access
Abstract 2467: Role of adrenomedullin in woodchuck hepatocarcinogenesis
Cancer Research·2010
Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection
Hepatology·2007· 22 cited
Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection
Gastroenterology·2004· 142 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Bud C. Tennant(10), Andrei V. Gudkov(10), Anatoli S. Gleiberman(8), Paul J. Côté(7), Marina P. Antoch(7), Stephan Menne(6), Brent E. Korba(6), John L. Gerin(6), Karen K. Kuropatwinski(5), James R. Jacob(4), Lyudmila G. Burdelya(4), B. H. Baldwin(3), Olga Chernova(3), Michelle Wrobel(3), Ilya Gitlin(3), Alan D. Hutson(3), Ekaterina L. Andrianova(3), T. Kirev(3), Parviz M. Pour(3), Leslie Curtin(3)